PMDIY (Pro Medicus) Operating Income: $117.3 Mil (TTM As of Dec. 2025)


PMDIY Pro Medicus Ltd PMDIY
77 GF Score
Price $30.00
GF Value $39.87
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Pro Medicus Operating Income?

Pro Medicus PMDIY +3.45% 77 Operating Income is $117.3 Mil as of Dec. 2025. GuruFocus rates PMDIY with a GF Score™ of 77/100 and a GF Value™ of $39.87 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Pro Medicus's Operating Income for the six months ended in Dec. 2025 was $60.2 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was $117.3 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. Pro Medicus's Operating Income for the six months ended in Dec. 2025 was $60.2 Mil. Pro Medicus's Revenue for the six months ended in Dec. 2025 was $82.9 Mil. Therefore, Pro Medicus's Operating Margin % for the quarter that ended in Dec. 2025 was 72.65%.

Good Sign:

Pro Medicus Ltd operating margin is expanding. Margin expansion is usually a good sign.

Pro Medicus's 5-Year average Growth Rate for Operating Margin % was 5.90% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Pro Medicus's annualized ROC % for the quarter that ended in Dec. 2025 was 62.80%. Pro Medicus's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 535.54%.

Pro Medicus  (OTCPK:PMDIY) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Pro Medicus's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=120.436 * ( 1 - 29.62% )/( (75.758 + 194.19)/ 2 )
=84.7628568/134.974
=62.80 %

where

Invested Capital(Q: Jun. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=220.51 - 8.564 - ( 136.188 - max(0, 28.085 - 182.353+136.188))
=75.758

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=354.759 - 12.006 - ( 148.563 - max(0, 32.682 - 203.439+148.563))
=194.19

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Pro Medicus's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=120.436/( ( (1.801 + max(18.401, 0)) + (2.071 + max(22.704, 0)) )/ 2 )
=120.436/( ( 20.202 + 24.775 )/ 2 )
=120.436/22.4885
=535.54 %

where Working Capital is:

Working Capital(Q: Jun. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(41.712 + 0.064 + 4.281) - (8.564 + 15.111 + 3.981)
=18.401

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(50.517 + 0.056 + 4.303) - (12.006 + 2.817 + 17.349)
=22.704

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. Operating Income is also linked to Operating Margin %:

Pro Medicus's Operating Margin % for the quarter that ended in Dec. 2025 is calculated as:

Operating Margin %=Operating Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=60.218/82.884
=72.65 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.

Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.

Pro Medicus Operating Income Related Terms

Pro Medicus Operating Income Historical Data

* Premium members only.

The historical data trend for Pro Medicus's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pro Medicus Operating Income Chart

Pro Medicus Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.37 43.80 56.22 74.49 102.61

Pro Medicus Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.73 42.02 44.26 57.11 60.22
PMDIY
77GF Score
Pro Medicus Ltd PMDIY
Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pro Medicus Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $117.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Income →
What does a Operating Income of $117.3 Mil mean?
Pro Medicus (PMDIY) has a Operating Income of $117.3 Mil as of Dec. 2025. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Pro Medicus and its competitors.
Is Pro Medicus' Operating Income too high?
Pro Medicus' current Operating Income is $117.3 Mil. Overall, Pro Medicus has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pro Medicus' Operating Income compare to VEEV and BTSG?
Pro Medicus' Operating Income of $117.3 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Income for a Healthcare Providers & Services company?
A good Operating Income depends on the Healthcare Providers & Services industry context. However, Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Income mean?
A high Operating Income can signal that a stock is expensive relative to its fundamentals. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on Pro Medicus and its competitors. Pro Medicus's current Operating Income is $117.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pro Medicus stock overvalued right now?
Based on GuruFocus' analysis, Pro Medicus (PMDIY) is currently considered Modestly Undervalued. The stock's GF Value™ is $39.87, compared to a current price of $30.00 — trading 24.8% below its estimated fair value. The current Operating Income is $117.3 Mil. Pro Medicus' overall GF Score™ is 77/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Income calculated?
Operating Income is calculated from a company's financial statements. For Pro Medicus (PMDIY), the current Operating Income is $117.3 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pro Medicus (PMDIY) Overvalued in 2026?

Based on GuruFocus' analysis, Pro Medicus stock appears to be undervalued. The current stock price of $30.00 is trading 24.8% below its estimated GF Value™ of $39.87. GuruFocus considers Pro Medicus to be Modestly Undervalued.

Key valuation signals for PMDIY:

  • Operating Income: $117.3 Mil
  • GF Value™: $39.87 vs. price of $30.00 (24.8% below fair value)
  • GF Score™: 77/100 with 1 warning sign

No single metric tells the full story. See the PMDIY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pro Medicus Business Description

Address 450 Swan Street, Richmond, VIC, AUS, 3121
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are US private academic hospitals. In fiscal 2025, Pro Medicus earned 90% of revenue in North America, 8% from Australia, and the remaining 2% in Europe.
77GF Score

Get the complete analysis for PMDIY

Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$30.00
Price
$39.87
GF Value